135 related articles for article (PubMed ID: 23819460)
1. Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade.
Yung MM; Chan DW; Liu VW; Yao KM; Ngan HY
BMC Cancer; 2013 Jul; 13():327. PubMed ID: 23819460
[TBL] [Abstract][Full Text] [Related]
2. Effect of taxol on the expression of
Liu Z; Xiao YU; Ning S; Li ZY; Zhu Y; Hu G
Oncol Lett; 2016 Jun; 11(6):4035-4039. PubMed ID: 27313736
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.
Gartel AL
Scientifica (Cairo); 2014; 2014():596528. PubMed ID: 25093142
[TBL] [Abstract][Full Text] [Related]
4. Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.
Irie H; Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Lett; 2016 Feb; 11(2):1287-1293. PubMed ID: 26893732
[TBL] [Abstract][Full Text] [Related]
5. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.
Han K; Pintilie M; Lipscombe LL; Lega IC; Milosevic MF; Fyles AW
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):507-12. PubMed ID: 26721670
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of metformin in gynecologic oncology.
Imai A; Ichigo S; Matsunami K; Takagi H; Yasuda K
Oncol Lett; 2015 Aug; 10(2):577-582. PubMed ID: 26622536
[TBL] [Abstract][Full Text] [Related]
7. Old drug, new trick: repurposing metformin for gynecologic cancers?
Febbraro T; Lengyel E; Romero IL
Gynecol Oncol; 2014 Dec; 135(3):614-21. PubMed ID: 25455733
[TBL] [Abstract][Full Text] [Related]
8. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
9. Resistance to HER2-targeted therapies: a potential role for FOXM1.
Peake BF; Nahta R
Breast Cancer Manag; 2014; 3(5):423-431. PubMed ID: 25598845
[TBL] [Abstract][Full Text] [Related]
10. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy.
Aytes A; Mitrofanova A; Lefebvre C; Alvarez MJ; Castillo-Martin M; Zheng T; Eastham JA; Gopalan A; Pienta KJ; Shen MM; Califano A; Abate-Shen C
Cancer Cell; 2014 May; 25(5):638-651. PubMed ID: 24823640
[TBL] [Abstract][Full Text] [Related]
11. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.
Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J
Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Metabolic Paradigms in Cancer and Diabetes.
Bosso M; Haddad D; Al Madhoun A; Al-Mulla F
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255314
[TBL] [Abstract][Full Text] [Related]
14. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma.
Luan H; Jian L; He Y; Zhang T; Zhou L
Sci Rep; 2022 Jul; 12(1):13002. PubMed ID: 35906389
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective.
Bou-Fakhredin R; De Franceschi L; Motta I; Cappellini MD; Taher AT
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745672
[TBL] [Abstract][Full Text] [Related]
16. Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers.
Yung MMH; Siu MKY; Ngan HYS; Chan DW; Chan KKL
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743298
[TBL] [Abstract][Full Text] [Related]
17. Urushiol V Suppresses Cell Proliferation and Enhances Antitumor Activity of 5-FU in Human Colon Cancer Cells by Downregulating FoxM1.
Jeong JH; Ryu JH
Biomol Ther (Seoul); 2022 May; 30(3):257-264. PubMed ID: 35264465
[TBL] [Abstract][Full Text] [Related]
18. Selenite-induced ROS/AMPK/FoxO3a/GABARAPL-1 signaling pathway modulates autophagy that antagonize apoptosis in colorectal cancer cells.
Yu H; Huang Y; Ge Y; Hong X; Lin X; Tang K; Wang Q; Yang Y; Sun W; Huang Y; Luo H
Discov Oncol; 2021 Sep; 12(1):35. PubMed ID: 35201430
[TBL] [Abstract][Full Text] [Related]
19. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
[TBL] [Abstract][Full Text] [Related]
20. Quantitative model of eukaryotic Cdk control through the Forkhead CONTROLLER.
Barberis M
NPJ Syst Biol Appl; 2021 Jun; 7(1):28. PubMed ID: 34117265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
